Diality Inc., a medical device company based in Irvine, California, is pleased to announce that Ravi Parthasarathy has joined the company as Chief Technology Officer. With years of experience in product development team leadership, Parthasarathy most recently worked at ICU Medical as Vice President of Device Engineering. Before that, he held leadership roles at Baxter Healthcare, Motorola, Siemens Medical Systems, and General Motors.
Osman Khawar, M.D., CEO of Diality expressed his excitement about Parthasarathy joining the team, noting his experience in developing innovative products and his alignment with Diality’s mission and values. Clayton Poppe will also take on the role of Chief Scientific Officer (CSO) to lead the company’s research, quality, and regulatory functions.
Parthasarathy shared his enthusiasm for contributing to the development of Diality’s flagship product, the Moda-flxTM Hemodialysis System. He highlighted the importance of innovation in improving the quality of life and care for dialysis patients. The Moda-flxTM Hemodialysis System aims to provide healthcare professionals with the tools to make patient-centered decisions and improve clinical practice. It is not yet approved for sale in any region. For more information about Diality and its products visit www.diality.com or find Diality on LinkedIn. For media inquiries please contact Sam Choinski at Pazanga Health Communications at schoinski@pazangahealth.com or (860) 301-5058.
